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Obstructive sleep apnea (OSA) is a highly prevalent condition that is associated with sig-
nificant neurobehavioral impairments. Cognitive abnormalities identified in individuals with
OSA include impaired verbal memory, planning, reasoning, vigilance, and mood. Therapy
for OSA improves some but not all neurobehavioral outcomes, supporting a direct role for
OSA in brain dysfunction and raising the question of irreversible injury from OSA. Recent
clinical studies have refined the neurobehavioral, brain imaging, and electrophysiological
characteristics of OSA, highlighting findings shared with aging and some unique to OSA.
This review summarizes the cognitive, brain metabolic and structural, and peripheral nerve
conduction changes observed in OSA that collectively provide a distinct phenotype of OSA
brain injury and dysfunction. Findings in animal models of OSA provide insight into molec-
ular mechanisms underlying OSA neuronal injury that can be related back to human neural
injury and dysfunction. A comprehensive phenotype of brain function and injury in OSA is
essential for advancing diagnosis, prevention, and treatment of this common disorder.
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OBSTRUCTIVE SLEEP APNEA: CLINICAL OVERVIEW
Obstructive sleep apnea (OSA) is a chronic sleep state-dependent
breathing disorder. This is a prevalent condition, observed in 5–7%
of general (adult and children) populations within most developed
and developing countries (Young et al., 1993; Punjabi, 2008). The
predisposing factor for OSA is a highly collapsible upper airway,
and the pathophysiology of the disorder may be summarized as
intermittent occlusions of the upper airway occurring exclusively
in sleep. In wakefulness upper airway patency in individuals with
OSA is maintained by upper airway dilator muscle activation.
A normal physiological effect of sleep is reduced tone in many
muscle groups, including upper airway dilator muscles (Rem-
mers et al., 1978). Upon arousal, pharyngeal patency is restored
(Remmers et al., 1978; Dempsey et al., 2010). These obstructive
sleep-disordered breathing events occur 5–120 times/h of sleep in
patients depending upon severity of OSA. Because of muscle ato-
nia and reduced chemosensitivity in rapid-eye-movement (REM)
sleep, the frequency of apneas and the severity of oxygen desatu-
rations are frequently more severe in REM sleep (Skatrud et al.,
1990).
Overall, most conditions that predispose an individual to
increased collapsibility of the upper airway are major risk fac-
tors for OSA. Given the high prevalence, obesity is the great-
est risk factor for increased upper airway collapsibility and
OSA. Increased adiposity results in fat deposits within pha-
ryngeal muscles and other soft tissues surrounding the airway.
OSA severity can improve with substantial weight loss, while
the prevalence of OSA continues to increase as obesity esca-
lates (Vgontzas et al., 1994; Park et al., 2011). Adenotonsillar
tissue also increases airway collapsibility and the likelihood of
OSA, and in children, pharyngeal lymphoid tissue is a major
cause of OSA (Fregosi et al., 2003; Dayyat et al., 2009). Recently,
however, obesity has become an important risk factor for OSA
in children, particularly adolescents (Gozal and Kheirandish-
Gozal, 2007, 2009; Bourke et al., 2011a,b). Micrognathia, ret-
rognathia, and maxillary insufficiency also predispose to OSA.
These conditions may occur as isolated conditions or as one
characteristic of several craniofacial syndromes that also result
in impingement on the upper airway, for example, Down’s syn-
drome, Treacher Collins and Pierre Robin syndrome (Kent et al.,
2010). Chronic nasal obstruction from allergies or nasal polyps
are additional predisposing factors for a collapsible upper air-
way and OSA (Dempsey et al., 2010). Supine positioning can
worsen the severity of OSA in individuals, and lateral positioning
for sleep may improve OSA in some individuals (Heinzer et al.,
2012).
Obstructive sleep apnea can be effectively treated with the
use of continuous positive airways pressure (CPAP) therapy, an
approach that stents open the upper airway with positive pressure.
While CPAP is highly effective in most individuals in alleviating
apneas, to maintain this positive pressure in the pharyngeal lumen,
a tightly fitting mask must be applied over the nose and/or mouth.
Adherence with CPAP therapy is reported between 30 and 60%
of patients (Weaver and Sawyer, 2010). Predictors of adherence
include sleepiness, severity of OSA, claustrophobia, side effects
from the therapy, patient education, and psychological well-being
and support (Weaver and Sawyer, 2010). There are other options
for OSA therapy including a mouthpiece that closes the jaw and
advances the mandible, lateral positional therapy (as described
above), and pharyngeal surgery to reduce soft tissue. In general,
substantial resolution of severe OSA is unlikely with these non-
CPAP therapies; thus, CPAP is recommended for all individuals
with moderate to severe OSA or symptomatic OSA, regardless of
severity.
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Obstructive sleep apnea is a relatively recently appreciated
disorder, one with phenotypes still being built. OSA has been
described in medical literature for less than 50 years (Guillem-
inault et al., 1975). Only within the past 25 years has the disorder
been considered as a potential contributor to neurobehavioral
and cardiovascular abnormalities, and only recently has OSA been
widely recognized as an important source of neurobehavioral and
cardiovascular morbidity (Kales et al., 1985; Bhattacharjee et al.,
2009; Lavie, 2009; Peppard, 2009). Intriguingly, the severity of
OSA does not always predict morbidities, and there are subgroups,
as yet to be defined, of patients with increased susceptibility to
OSA complications, including cognitive impairments. This review
serves to update and integrate the neurobehavioral, imaging, and
electrophysiological phenotypes of OSA.
ACUTE PHYSIOLOGICAL DISTURBANCES IN OSA
Obstructive sleep-disordered events have substantial effects on
both hemodynamics and gas exchange that, in turn, influence
brain health and function. As mentioned above, individuals with
OSA rely upon upper airway dilator muscles surrounding the air-
way to stent the pharynx open. In sleep, tone in these muscles
is reduced, and the pharynx is prone to collapse. When collapse
occurs, larger attempts by the ventilatory pump muscles (e.g., the
diaphragm) against a closed pharynx lower the intrathoracic pres-
sure (Dempsey et al., 2010). The lower pressure reduces cardiac
preload and increases cardiac afterload, thereby compromising
cardiac blood flow (Scharf et al., 1992). At the same time the
collapsed upper airway prevents gas exchange, thereby allowing
arterial carbon dioxide to rise and oxygen to fall. The fall in oxy-
gen is in part determined by central obesity, where the greater
the abdominal obesity, the more quickly and profoundly oxygen
will fall. The gas exchange interruption results in increasing sym-
pathetic drive and arterial resistance, further challenging cardiac
output. Both hypercapnia and upper airway sensory stimulation
contribute to arousal and restoration of upper airway patency.
Restoration of the patent airway, in turn, improves both pre-
load and afterload, thereby suddenly increasing cardiac output
and sympathetic activity (Dempsey et al., 2010). The increased
cardiac output and sympathetic drive result in large increases in
blood pressure. In individuals with severe OSA, systolic blood
pressures may be higher in sleep than in waking. Fluctuations in
carbon dioxide levels can perturb central nervous system arterial
blood flow (Foster et al., 2009; Furtner et al., 2009). The frequent
hypoxia/reoxygenation events impose significant oxidative stress
on the brain, and increased sympathetic drive increases coagula-
bility (both platelet and clotting factor activation) throughout the
body, including the brain (Li and Veasey, 2012), while repeated
arousals from obstructive breathing events result in significant
sleep disruption. A recent study suggests that vibratory trauma
modeling snoring vibrations can increase carotid artery endothe-
lial damage (Cho et al., 2011). Any, or all, of these perturbances
may contribute to the neurobehavioral sequelae of OSA.
COGNITIVE FUNCTION IN INDIVIDUALS WITH OSA
Sleepiness, mood disturbances, and cognitive dysfunction are fre-
quently observed in individuals with OSA. Sleepiness is the most
common symptom in OSA (Engleman and Joffe, 1999). Sleepiness,
measured objectively with the multiple sleep latency test and main-
tenance of wakefulness test or subjectively using the Epworth or
Stanford sleepiness scales, is evident in most, but not all, individ-
uals with OSA (Patel et al., 2003). Sleepiness typically improves
in OSA after initiation of CPAP therapy. However, if sleepiness
is severe at baseline, complete reversal of sleepiness is unlikely
(Patel et al., 2003; Antic et al., 2011). The incomplete reversal with
effective therapy suggests either additional causes of sleepiness or
irreversible injury to neural circuits involved in sleep/wakefulness
and alertness (Antic et al., 2011). To explore reasons for resid-
ual sleepiness in treated OSA, Vernet et al., compared subjects
treated for OSA with and without residual sleepiness and non-OSA
subjects. Participants with primary sleep disorders, insufficient
sleep time, and lifelong sleepiness were excluded from the study.
They found that individuals with OSA and residual sleepiness fol-
lowing effective therapy also had reduced stage N3 (slow wave
or deep) sleep, higher depression indices, and increased periodic
limb movements. While these findings are consistent with post-
hypoxic injury to monoaminergic neurons, it is also possible that
the sleepiness could be secondary to depressive symptomatology
or idiopathic hypersomnolence (Vernet et al., 2011). Future stud-
ies are needed to follow individuals across the progression from
benign snoring to OSA to determine whether OSA can result in
lasting hypersomnolence.
Not all patients with OSA have cognitive abnormalities, and
most of the studies finding significant differences in cognitive
function have examined individuals with severe OSA. Kales et
al., performed a vast array of neurobehavioral tests in subjects
with and with out OSA to identify psychosocial and cognitive
disturbances in severe OSA. In a study of 50 individuals with
severe OSA, 76% of subjects with OSA had significant cognitive
abnormalities, including disturbances in mood, thought process-
ing, memory, communication capabilities, and attention (Kales
et al., 1985). The most common mood disturbance in OSA is
depression. Clinically significant depression is observed in half of
all patients with moderate-severe OSA (Engleman and Douglas,
2004; Aloia et al., 2005). The high prevalence of depression in
OSA has been confirmed in a more recent studies (El-Sherbini
et al., 2011). That OSA therapy improves mood supports a direct
relationship between OSA and depression. Decrements in vigi-
lance and attention can also be quite profound in OSA. Attentional
deficits in OSA contribute to increased risk of motor vehicle acci-
dents. As observed with depression and sleepiness, treating OSA
improves attention and reduces motor vehicle risk (Sassani et al.,
2004). Impaired attention can negatively influence many, but not
all, performances in neurobehavioral tests. Memory (semantic,
episodic, and working domains) can be examined independent of
attention. In OSA, verbal memory is impaired in all three domains;
while visual memory appears unaffected by OSA (Twigg et al.,
2010). Whether verbal memory improves with OSA therapy has
not been determined. One caution with interpreting results of
this study is that while neurological disease and diabetes were
excluded, obesity was present only in the OSA group, and obesity
is also a risk factor for poor cognitive function (Sellbom and Gun-
stad, 2012). Clearly determining how OSA and obesity influence
cognitive performance will be important to discern. Subjective
quality of life disturbances observed in OSA, including perceived
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poor social interactions, emotional instability, and reduced vital-
ity, also improve significantly with effective therapy (Jenkinson
et al., 1999). Executive function includes verbal reasoning, plan-
ning, attention, and problem solving. Deficits in each of these
skills are observed in OSA, and there are important associations
between the severity of hypoxemia and cognitive impairment
(Carlson et al., 2011). Unlike attention, sleepiness and mood, exec-
utive function impairments in OSA are less likely to reverse with
CPAP therapy (Lau et al., 2010; Saunamaki et al., 2010; Hong
et al., 2012). Whether the persistent deficits represent irreversible
injury from OSA or injury from another disorder or condition
requires further study. It is important to recognize that most neu-
robehavioral studies are carried out on small sample sizes and, at
the same time, have performed numerous independent behavioral
tests within the same study. Thus,most OSA neurobehavioral stud-
ies are underpowered for excluding cognitive impairments. One
of the most intriguing recent studies on cognitive function and
OSA is the study by Canessa et al. (2011) in which subjects with
severe OSA had impaired performances on most cognitive tests
and several lesions by magnetic resonance imaging. With therapy,
both cognitive testing and imaging abnormalities improved in par-
allel. Whether the imaging abnormalities represent true neuronal
changes or vascular changes and why these patients showed com-
plete normalization in cognitive function after therapy will require
further study. Children with OSA may also show cognitive deficits,
that cannot be explained by obesity or cardiovascular disease.
In young children without obesity, Barnes et al. (2012) identi-
fied significant visual attention deficits and learning and memory
impairments in young children (4–8 years) with OSA. Impaired
performance could be predicted by evoked potential testing during
an attention task. Evoked potential testing during polysomnogra-
phy might identify children at risk for cognitive dysfunction form
OSA. This is, indeed, an area in need of careful, rigorous stud-
ies designed to identify additional causes of cognitive dysfunction
in this patient population and to follow function across longer
periods of therapy.
IS COGNITIVE DYSFUNCTION IN OSA CONSISTENT WITH
AGING?
The above clinical studies provide strong evidence that OSA con-
tributes to brain dysfunction and that treating OSA improves
neurobehavioral outcomes. Advanced aging is a ubiquitous insult
to brain function, and many of the cognitive abnormalities (e.g.,
verbal memory, reaction time, and executive function) observed
in OSA are also seen with aging. Whether OSA represents a dis-
tinct singular event brain injury irrelevant of aging, a continuous
injury with no influence on aging, or whether OSA injury directly
influences aging injury will be important to discern. A few age-
OSA studies have been performed with negative results. Two small
cross-sectional studies found no effect of OSA on age-related cog-
nitive function (Mathieu et al., 2008; Sforza et al., 2010). Alchanatis
et al. (2004) have shown that middle-aged individuals with OSA
have more cognitive impairment than age-matched controls, while
younger individuals with OSA appear similar to controls. Younger
individuals with OSA show brain activation (by functional mag-
netic resonance imaging) in verbal and attention cognitive tasks
and do not have impaired performance. In contrast, middle-aged
individuals with OSA do not show brain activation and have
impaired performances, suggesting that OSA and aging are addi-
tive (Ayalon et al., 2010). Alternatively a longer duration of OSA
may worsen compensatory mechanisms. Future prospective stud-
ies will be helpful to elucidate the relationship between aging and
OSA effects on cognition.
Newer study designs implemented for aging and cognitive
function studies use within subject longitudinal analysis and are,
therefore, far more sensitive at detecting differences. For example,
older cross-sectional studies identified the beginning of decline
in cognition with aging to be around 60 years of age. Recent lon-
gitudinal studies using within subject analysis across time offer
discouraging news: the decline begins much earlier. In the large
Whitehall series in Great Britain (over 7000 subjects), adults rang-
ing in age from 45 to 70 years at the start of the study were followed
with cognitive tests for 10 years to allow within subject compar-
isons with time. Executive functions including reasoning, memory,
and verbal fluency, declined in all age groups including 45–49-
year-olds. In contrast, vocabulary was largely unaffected across the
10 years for any age groups. Declines for males and females were
similar, and the amount of decline across 10 years was similar for
all tests, except reasoning, which plummeted more dramatically in
the older groups. Recently a sub-analysis of the data found that
changes in total sleep times between tests were associated with
poorer cognition. While the executive function impairments in
OSA are consistent with those observed across aging, sleepiness,
and reduced vigilance observed with OSA are not observed in
healthy aging at least not before age 80. The marked sleepiness and
impaired vigilance suggest a distinct process unrelated to aging. To
carefully examine interactions between aging and OSA, longitudi-
nal examinations of verbal executive function in individuals with
and without OSA are needed.
BRAIN IMAGING IN OSA
Imaging studies of the brains of individuals with and without OSA
have revealed distinct regional metabolic disturbances and gray
and white matter abnormalities. Proton magnetic resonance spec-
troscopy (PMRS) provides a window into brain metabolism. N -
acetylaspartate (NAA) is a marker of active neurons, and choline
(cho) indicates cell membranes, while creatinine (cr) marks energy
metabolism. Thus, a low NAA/cho or low NAA/cr indicate reduced
viable neurons within the region measured. Kamba et al. (1997)
examined 23 subjects (aged 24–75 years) and 15 controls find-
ing significantly reduced NAA/cho in the cerebral white matter
in individuals with moderate-severe OSA, while individuals with
mild OSA showed no differences. The researchers performed a
follow-up study excluding individuals with diabetes and hyper-
tension that might confound results and found that the severity
of OSA predicted cerebral white matter reductions in NAA/cho
(Kamba et al., 2001). Two other small studies examining NAA/cr
in OSA and control subjects found reduced NAA/cr in the hip-
pocampus (Bartlett et al., 2004) and throughout the cerebral white
matter (Alchanatis et al., 2004). A more recent study by Tonon
et al. (2007) found reduced NAA in the cerebral cortex in OSA
subjects with sleepiness but without other cognitive abnormali-
ties. This work supports the concept that PMRS could be used
in early detection of brain injury before cognitive impairments.
www.frontiersin.org October 2012 | Volume 3 | Article 139 | 3
Veasey Sleep apnea neural injury
Importantly, in this same study, patients were then treated with
CPAP for 6 months and re-examined (Tonon et al., 2007). The
reduced cortical NAA did not reverse. Another way to characterize
brain metabolics is with 31P PMRS, measuring ATP and metabo-
lites. In severe untreated OSA subjects with>10% sleep time spent
with hypoxemia, ATP levels (measured for the whole forebrain)
are reduced during sleep (Tonon et al., 2007). One of the most
striking sets of findings involves NAA measures in children with
OSA. Halbower et al. (2006) examined 33 children (6–16 years)
with OSA and 12 controls. In children with OSA, as previously
shown in adults, NAA was reduced in the right hippocampus
and frontal cortex. These reductions were associated with reduced
intelligence quotients (IQ’s) and school performance (Halbower
et al., 2006). There are two small reports suggesting a negative
relationship between obesity and NAA/cr (Gazdzinski et al., 2008,
2010). In these studies OSA was not excluded, and it is possible
that OSA contributes to the reduced NAA in obesity. Future stud-
ies are necessary to discern whether obesity contributes directly to
the reduced NAA in OSA.
A number of studies have compared OSA and non-OSA white
and gray matter volumes using magnetic resonance imaging
(MRI). Macey et al. (2002) examined male subjects (aged 25–70)
with moderate-severe OSA and normal healthy controls and found
that while gray matter declined across ages studied in controls, val-
ues were reduced in young OSA subjects and were not lower with
age. These results are more consistent with a single hit from OSA
on brain morphology rather than accelerated aging changes. In
OSA, gray matter lesions were identified in the frontal and parietal
cortex, the right hippocampus, and deep cerebellar nuclei (Macey
et al., 2002). Morrell et al. (2003) confirmed hippocampal gray
matter loss in severe OSA; although her group did not confirm
cortical gray matter losses. Thomas et al. (2005) examined func-
tional MRI responses to a verbal memory task in 16 very severe
OSA subjects (21–50 years) and 16 age-matched controls, finding
impaired verbal memory with reduced prefrontal cortex activa-
tion responses in OSA subjects. After 2 months+ CPAP therapy,
repeat imaging showed minimal improvement, with no improve-
ments in prefrontal cortex inactivation. Others have also observed
reduced frontal activation with memory tasks in OSA (Ayalon
et al., 2009a,b; Zhang et al., 2011),although patients with less severe
OSA may have compensatory (increased activation) responses
(Ayalon et al., 2009b). It is important to acknowledge that there is
one MRI study with negative gray matter findings (O’Donoghue
et al., 2005). O’Donoghue et al., examined 27 subjects with OSA
and 24 controls. As a group, the OSA subjects had a mean Epworth
sleepiness score of 13,demonstrating group sleepiness. No regional
reductions in gray matter were identified (O’Donoghue et al.,
2005). A follow-up study by the same research group with larger
sample sizes (adequately powered to detect differences) found
gray matter lesions in the temporal gyrus (frontal cortex) and
cerebellum (Morrell et al., 2010). Using a newer, more sensitive
methodology, diffusion tensor imaging with fractional anisotropy,
Macey et al. (2008) identified substantial white matter lesions in
OSA, largely throughout the brain but with more pronounced
changes in the cortices, limbic system, pons, and cerebellum tracts.
Perhaps the most intriguing study is the recent study by Canessa
et al., in which severe OSA subjects with sleepiness, depression,
and neurobehavioral abnormalities had, as expected from other
studies, reduced gray matter volumes in the hippocampus and
fronto-parietal cortices. The surprising finding was that with
CPAP therapy, cognitive performance normalized, as did gray mat-
ter lesions. In fact, cognition and morphology changed in parallel
with therapy. While these findings require replication to determine
whether there was something unique about this population, the
results demonstrate the importance of effective therapy for OSA.
In summary, there are significant reductions in neuron metabo-
lite measures suggesting injured, non-viable neurons in particular
brain regions, including the frontal cortex and hippocampus. Of
concern, these changes are also observed in children, and in some
children and adults the abnormalities are not reversed with ther-
apy. It will be important to discern obesity changes from OSA
changes with future studies. In addition there is significant gray
matter loss in OSA, with the hippocampus being most sensitive to
gray matter loss in OSA. There is one study suggesting improve-
ment in gray matter lesions with CPAP therapy. Newer fractional
anisotropy MRI studies find substantive white matter injury in
OSA. While expensive and labor intensive, brain-imaging stud-
ies provide valuable temporal windows into brain morphology of
OSA.
There are some interesting similarities between imaging find-
ings in OSA and aging in that the brain regions affected in OSA are
similar to brain regions most vulnerable in aging. Specifically, the
frontal cortex (central to executive function) white and gray matter
decline with aging, as does hippocampal volume (Michielse et al.,
2010; Schulze et al., 2011; Taki et al., 2011a,b). Newer longitudi-
nal studies show healthy age-related changes in both white matter
tracts (using fractional anisotropy); reduced hippocampal activa-
tion upon relevant task (functional MRI), and measurable cortical
gray matter changes over, incredibly, a 1–2 year period (Fjell et al.,
2009; Nyberg et al., 2010; O’Brien et al., 2010; Teipel et al., 2010;
Cardenas et al., 2011). Annual decline in cortical volume in healthy
individuals over age 60 years is 0.5%, with steeper declines in older
individuals (Fjell et al., 2009; Nyberg et al., 2010). These same
regions are susceptible to larger volume losses in individuals with
mild cognitive impairment or Alzheimer’s disease. Involvement
of the same regions does not implicate the same pathogenesis in
OSA, aging, and Alzheimer’s, but rather highlights the neural tissue
most vulnerable to diverse insults. A next important step in OSA
is to determine if the changes across time in individuals with OSA
are closer to those expected for healthy aging or those observed in
Alzheimer’s and mild cognitive impairment. Whether treatment
of OSA lessens neural volume loss across time, in parallel with
less behavioral decline would be extremely important to discern
as well.
NERVE CONDUCTION DEFECTS IN OSA
Peripheral nerve conduction studies might provide an important
functional window into OSA neural injury. However, there are
only a few studies reporting peripheral nerve conduction char-
acteristics in individuals with OSA. One of the first studies was
a case series study. In seven individuals diagnosed with severe
OSA, four had phrenic nerve conduction delays (Lu et al., 1998).
Mayer et al. (1999) found markedly reduced median nerve ampli-
tudes and reduced conduction velocity in individuals with severe
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OSA. Peripheral neuropathy may also contribute to erectile dys-
function (increased prevalence with OSA). Men with severe OSA
have impaired bulbocavernosus reflex responses with prolonged
nerve conduction latencies and reduced amplitude (Fanfulla et al.,
2000). Most compelling is a recent study by Dziewas et al. (2007) in
which sural nerve amplitudes were measured in individuals with
and without OSA (wide range of ages/severity). Sensory nerve
amplitudes were reduced by 45%. Less than half of the subjects
used CPAP after the initial studies. In these individuals, sural nerve
amplitude abnormalities partially reversed, while in non-treated
OSA subjects no change was observed (Dziewas et al., 2007). These
data strongly support a direct injury to peripheral nerves in OSA.
Clearly large-scale studies are needed in children and adults to
determine the prevalence and reversibility of peripheral neuropa-
thy in OSA. Future studies are needed to relate peripheral nerve
findings with cognitive function and brain imaging in OSA. If
cognitive performance declines in OSA in parallel with periph-
eral nerve conductance abnormalities, the latter would provide a
simple relatively inexpensive screening tool for OSA neural injury.
Ultimately blood or urine biomarkers for OSA phenotypes should
be an important direction.
CEREBROVASCULAR DISEASE IN OSA
Clinical studies demonstrate strong associations between cere-
brovascular disease and OSA, and this, too, may contribute to
cognitive dysfunction in OSA. In a prospective study of over
5,000 subjects followed for almost 9 years, moderate-severe OSA
is an independent risk factor for cerebrovascular disease in men
(twofold increase in risk), yet in women, OSA does not appear to
be a significant independent risk factor for cerebrovascular disease
(Redline et al., 2010). Patients hospitalized with acute onset stroke
and who have OSA have improved outcomes (less impairment)
when treated with CPAP during rehabilitation hospitalization
(Ryan et al., 2011). The mechanisms underlying cerebrovascular
disease in untreated OSA are not established, but several recent
studies highlight potential sources of cerebrovascular injury in
OSA. First, there are impaired autonomic responses including
cerebrovascular responses to hypoxia in individuals with OSA
(Pizza et al., 2010). Following an apnea there is a large drop in
cerebral blood flow velocity that could be rather detrimental fol-
lowing hypoxia (Balfors and Franklin, 1994; Hajak et al., 1996).
The impaired responses promote large fluctuations in cerebral
hemodynamics. Cerebrovascular responses are further impaired
by reduced carbon dioxide vasodilatation (Morgan et al., 2010).
One of the most interesting risks for cerebrovascular disease is that
snorers have increased carotid atherosclerosis (Lee et al., 2008). A
direct link to vibratory trauma was recently demonstrated in a rab-
bit model where vibratory damage resulted in endothelial damage,
an important precursor to atherosclerosis (Cho et al., 2011). Future
studies examining the risk of snoring for atherosclerosis in distant
arteries and longitudinal studies in snorers will help identify the
relationship between snoring and atherosclerosis.
NEUROBEHAVIORAL MANIFESTATIONS IN ANIMAL MODELS
OF OSA
There are distinct advantages and disadvantages with studying ani-
mal models of a particular disease. If a study animal is otherwise
healthy, then an isolated anomaly can be tested for a direct link
with morbidities. Frequently, however, animal models are incom-
plete models of the disease and can provide supportive rather
than definitive information. The English bulldog is one of the few
natural animal models of OSA (Hendricks et al., 1987); although
most of the events are observed in REM sleep. The English bull-
dog has several relatively commonly occurring genetic anomalies,
including palate and spine defects and hydrocephalus, which may
influence OSA and/or cognitive function. Most other non-human
species have well-developed hyoid arches to protect the upper air-
way and are less likely to have obesity. Leptin deficient rodents are
obese and have increased upper airways resistance but do not evi-
dence apneas (Ray et al., 2007). Several rodent models have been
developed to examine the neural effects of long-term intermittent
hypoxia (LTIH), intermittent hypercapnia, and sleep fragmenta-
tion of cognitive function. Rodent models have the advantages of:
ready availability, low-cost, and the availability of genetic mod-
els that may be used to identify mechanisms of brain injury.
LTIH, modeling severe OSA oxygenation patterns (40 events/h
with oxygen saturation nadirs of 75%), in mice results in irre-
versible sleepiness with injury to and loss of catecholaminergic
wake neurons (Zhu et al., 2007). Whether more mild exposures
cause injury or wake impairments has not been explored. Neuronal
death is observed in neonatal rats exposed to both intermittent
hypercapnia and LTIH (Douglas et al., 2010), but whether the
neuronal loss contributes to cognitive impairments will require
further study. Exposure to severe OSA oxygen patterns in young
adult rats has been shown to impair spatial learning and memory,
with injury to a behaviorally relevant brain region, the hippocam-
pus (Gozal et al., 2001). Sleep fragmentation, modeling OSA
sleep disruption, induces comparable spatial learning and mem-
ory impairments (Nair et al., 2011), and LTIH impairs attentional
set shifting (the ability to focus on important stimuli) in rats
(McCoy et al., 2010). A more comprehensive OSA model (one
with sleep state-dependent obstructive apneic events) was devel-
oped recently (Neuzeret et al., 2011). This model has intermittent
hypoxemia, intermittent hypercapnia, hemodynamic changes as
in OSA, and sleep fragmentation, making this a much more com-
prehensive model of OSA in which to study neural injury. It will
be of great interest to determine whether the composite of physio-
logical disturbances in this model results in different or more pro-
nounced neurobehavioral impairments. Collectively, the present
data strongly support the concept that OSA physiological per-
turbances, including LTIH, hypercapnia, and sleep fragmentation
directly impair brain function and injure neurons, contributing to
impaired attention, wakefulness, and spatial memory.
Consistent with hippocampal lesions identified in OSA, LTIH
results in hippocampal-dependent learning and memory impair-
ments in young adult rats and mice (Gozal et al., 2001). LTIH
exposure is associated with behavioral impairments, oxidative,
inflammatory responses, and apoptosis changes have been iden-
tified in the CA1 region of the hippocampus in animals exposed
to LTIH (Li et al., 2003, 2004). Some of the molecular changes are
evident only in early injury. For example, inducible nitric oxide
synthase protein is elevated only in the first week of LTIH (Li
et al., 2004). There are several proteins that influence the vul-
nerability to LTIH spatial learning and memory impairments.
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Transgenic reduction in platelet activating factor improves spa-
tial learning and memory performances after LTIH (Reeves and
Gozal, 2004). Administration of catechin polyphenols or growth
hormone across LTIH exposure offers some protection (Burck-
hardt et al., 2008). Allowing physical activity of rodents during
LTIH prevents spatial learning and memory impairments (Gozal
et al., 2010). It is both encouraging and discouraging that there are
so many modifiers and seemingly so many pathways are involved
in LTIH cognitive impairment. On the optimistic side there are
many ways to protect the brain from injury. Regular exercise, green
tea (for catechin polyphenols) and adequate sleep time (to boost
growth hormone) may help confer resistance to LTIH and possi-
bly OSA neural injury. From the pessimistic perspective, perhaps
we have not found the mechanisms underlying OSA and LTIH
injury; we are simply improving general brain health. To reconcile
this concern requires testing both the presence of LTIH modified
pathway and the complete effects of both increasing and reducing
the molecule under examination.
Apneas may increase neural injury to a greater extent than inter-
mittent hypoxia. The brain, over other organs, may be uniquely
sensitive to recurrent apneas because of greater increases in oxy-
gen tension across time (Almendros et al., 2011). Almendros et al.
(2011) developed parallel rat models of intermittent hypoxia and
recurrent apnea and then measured tissue oxygen tension across
repeated events. Across time, muscle and visceral fat oxygen ten-
sions with repeated events did not change. In contrast, in the
cerebral cortex, there was a progressive increase in oxygen tension
values for both the peak and nadir of apneic events. This suggests
that vasoactive changes in response to apneas, but not intermittent
hypoxia influence the oxygen tension in the cortex. The cortex of
the brain but not muscle or fat in the apnea model showed reduced
glutathione supporting oxidative stress (Almendros et al., 2011).
One of the molecules that likely contributes directly to LTIH
injury is nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase. We have identified that LTIH in mice results in irreversible
wake impairments (Veasey et al., 2004). LTIH-exposed mice sleep
more during their active (subjective day) and inactive (subjective
night) periods. In a mouse version of the multiple sleep latency
test, mice exposed to LTIH fall asleep much earlier. LTIH induces
oxidative and nitrative stress in regions of wake active neurons,
manifested as increased tyrosine nitration, 8-, 12-isoprostanes, and
carbonyl protein levels (Zhan et al., 2005a,b). NADPH oxidase sub-
units are up-regulated and activated in wake regions in response
to LTIH (Zhan et al., 2005b). Moreover, mice with NADPH oxi-
dase inhibited across LTIH or mice with transgenic absence of the
NADPH oxidase isoform that is up-regulated in response to LTIH
(NADPH oxidase 2) the mice do not develop wake neuron injury
or sleepiness. Moreover, mice with absent or inhibited NADPH
oxidase 2, developed less inflammatory response to LTIH in the
brains and less nitration, oxidation (Zhan et al., 2005b; Zhu et al.,
2007). Thus, it is very likely that NADPH oxidase contributes to
the injury.
More recent studies have identified LTIH-induced up-
regulation of hypoxia inducible factor-1a (HIF-1a) and mito-
chondrial and endoplasmic reticulum injury (Douglas et al., 2010;
Prabhakar et al., 2010). NADPH oxidase and HIF-1a have bidirec-
tional positive feedback on each other in LTIH, so that inhibiting or
reducing one lowers the LTIH response of the other and in doing
so lessens injury. The next steps are to confirm in post-mortem
OSA brain tissue that NADPH oxidase is activated and to deter-
mine how NADPH oxidase is activated in the brain in LTIH and
OSA. Hypoxia can activate angiotensin 1A and result in NADPH
oxidase activation, and angiotensin 1A antagonists can reduce
NADPH oxidase activation. It will be of interest if angiotensin 1A
antagonists confer protection across time in cognitive and brain
morphology changes in individuals with OSA.
CONCLUSION
Collectively from studies performed over the past two decades, a
constellation of specific cognitive impairments, brain morphol-
ogy, and electrophysiological findings in OSA has developed. OSA
is not only associated with hypersomnolence, depression, poor
attention, impaired verbal memory, poor reasoning, and plan-
ning, but therapy for OSA can improve each of these findings.
Presently, some of the larger questions left unanswered include:
which patients with OSA are at risk for neural injury, and can
we prevent progression of neuronal injury? Which neural injuries
in OSA are irreversible? How do we identify those individuals
at risk for brain injury and dysfunction from OSA? Are there
markers, such as evoked potentials or electromyography that can
predict central injury and dysfunction? By piecing together this
more comprehensive phenotype (imaging, electrophysiology, and
behavioral testing) in future longitudinal studies with patient
characteristics, it is likely that many of these questions can be
answered.
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